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When developing animals encounter nutrient restriction, most tissues stop growing. Some vital
tissues, however, such as the brain, continue to grow. Now, Cheng et al. (2011) identify Alk as
the kinase that allows the Drosophila brain to continue growing during nutrient restriction by
bypassing the requirements for insulin receptor and TOR activation.Figure 1. Alk Enables Nutrient-Independent Growth in the CNS
One key signaling pathway regulating tissue growth is the insulin/TOR pathway. In most tissues except
brain, activation of insulin receptor (InR) by insulin-like peptides, as well as activation of TOR by nutrient
and growth factor signaling, are necessary for cells to grow. InR and TOR promote cell growth by regu-
lating the activity of multiple downstream effectors, including phosphoinositide 3-kinase (PI3K), S6K, and
4E-BP. In the absence of nutrients, signaling through these pathways is turned off, blunting growth (right-
side box). In contrast, in the brain, these downstream effectors are predominantly regulated by anaplastic
lymphoma kinase (Alk). Alk is activated in a nutrient-independent manner via its ligand Jelly belly, which is
expressed by neighboring glia. This allows brain tissue to grow also in the absence of InR and TOR
activation and, hence, in the absence of nutrients (left-hand box).Not all animal tissues are created equal.
Some enjoy preferential treatment if nutri-
ents become limiting. This happens, for
instance, in cases of intrauterine growth
restriction in which fetuses experience
inadequate nutrient and oxygen supply.
In such cases, fetal blood circulation gets
redistributed to preferentially perfuse the
brain, in an attempt to maintain its oxygen
supply (Roza et al., 2008). This is one of
potentially several mechanisms that lead
to ‘‘brain sparing,’’ whereby babies are
born smaller than normal but with propor-
tionally large heads (Gruenwald, 1963).
Differential size scaling of the brain versus
the rest of the body also occurs in res-
ponse to genetic variation in the human
population, wherein people of smaller
stature have proportionally larger heads
than people of larger stature (Koh et al.,
2005). Strikingly, analogous effects are
observed in insects such as the fruit fly
Drosophila, consistent with variable nu-
trient supply being an evolutionarily old
problem. In cases of insufficient nutrients,
flies grow smaller than normal but prefer-
entially spare the most important tissues
(Shingleton, 2010). A study by Cheng
et al. (2011) in this issue of Cell makes
significant progress toward understand-
ing how ‘‘high-priority’’ tissues maintain
growth when nutrients become scarce.
Cheng et al. find that, analogously to
humans, one organ that is strongly spared
in the larva is the brain. When nutrients
become restricted, larval brains continue
to grow despite low levels of insulin
peptides and low levels of amino acids
in circulation. Since insulin and TOR
signaling, which are normally activated
by insulin and amino acids, respectively,
are required in almost all tissues for
growth, this was a surprising result.346 Cell 146, August 5, 2011 ª2011 ElsevierSignaling through the insulin pathway is
normally ‘‘dominant’’ to nutrient avail-
ability, in that tissues with low insulin sig-
naling will not grow, even in the presence
of nutrients (Bo¨hni et al., 1999), whereas
tissues with elevated insulin signaling willInc.grow even in the absence of organismal
nutrient availability (Britton et al., 2002).
Therefore, the mechanisms regulating
tissue growth during nutrient restriction
are likely to intersect with the insulin
pathway, providing nutrient-insensitive
inputs to activate key components of
the pathway. Cheng et al. thus proceeded
to carefully test which components of the
insulin and TOR pathways are required for
brain growth. TOR regulates cell mass
accumulation in part via two well-des-
cribed effector targets that control trans-
lation, S6K and 4E-BP. Surprisingly, the
authors found that removing S6K or
4E-BP did indeed have profound effects
on brain growth. In contrast, removing
TOR did not. This poses a conundrum,
in that removing the upstream kinase,
TOR, does not affect brain growth,
whereas removing its effectors does!
Likewise, Gould et al. found that removing
the insulin receptor (InR) had no effect on
brain growth, whereas removing its down-
stream effector kinases, PI3K, Pdk1, and
Akt/PKB, did.
The authors solved this mystery by
postulating that another kinase must be
taking over the jobs of InR and TOR in the
brain, activating their downstream targets.
Indeed, by screening for kinases that are
required for brain growth, they identified
the postulated kinase to be anaplastic
lymphoma kinase (Alk). They found that
Alk in the brain is able to induce phos-
phorylation of the effector targets of InR
and TOR. Because the activating ligand
of Alk, Jelly belly, is expressed by glia in a
nutrient-independent manner, this allows
the brain to maintain growth during nu-
trient restriction (Figure 1). The authorsgo on to show that Alk overexpression
is sufficient to confer nutrient-dependent
growth to the salivary gland, a tissue
whose growth is normally limited during
nutrient restriction. One open question
warranting further investigation is how
Alk is able to activate the targets of InR
and TOR.
One key concept that emerges from this
study is that the connectivity architecture
of signaling pathways is not static in space
and time. Instead, it gets rewired depend-
ing on the tissue type and on inputs from
other signaling pathways. For a tissue to
grow during nutrient restriction, it needs
to activate key components of the insulin
and TOR pathway in a nutrient-indepen-
dent manner. Chen et al. show that, in
the brain, this occurs via Alk. Analogously,
tissue growth continues throughout pupal
stages, when animals have stopped
eating, due to nutrient-independent ex-
pression of an insulin-like peptide ILP6,
thereby activating the insulin pathway in
a nutrient-independent manner (Okamoto
et al., 2009; Slaidina et al., 2009). Finally,
when larvae are deprived of amino acids,
their imaginal discs can continue growing,
and this appears to bemediated via inputs
from ecdysone signaling (Mirth et al.,
2009).
These findings are also particularly in-
triguing from the cancer perspective. Due
to their capacities to drive tissue growth,
both insulin and TOR signaling are potentCell 1oncogenic pathways. The finding that Alk
can replace InR and TOR in the central
nervous system might explain why Alk
is frequently mutated in neuroblastoma
(Ogawa et al., 2011).REFERENCES
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